Immunocore Holdings Plc (IMCR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IMCR Annual Balance Sheets →
Quarterly balance sheet trends provide context on Immunocore Holdings Plc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent484.92
Marketable Securities, Current SH395.29
Cash & Short-term Investments879.00
Inventories0.00
Inventories7.79
Other Current Assets95.35
Prepaid Expense And Other Assets Current67.69
Total Current Assets1,051.04
Equipment/Property/Plant Net12.86
Income Taxes Receivable PR0.00
Intangible AssetsAnd Goodwill55.52
Total Assets1,119.42
Liabilities
Accounts Payable, Current AC26.32
Accrued Liabilities And Other Liabilities9.13
Other Liabilities, Current199.75
Total Current Liabilities235.20
Long-term debt394.21
Total Long-term Debt394.21
Accrued Income Taxes, Noncurrent0.00
Noncurrent Provisions70.22
Total Liabilities699.62
Stockholders' Equity
Common Stock Value0.14
Additional Paid In Capital Common Stock1,273.10
Retained Earnings / Accumulated Deficit-819.11
Accumulated Other Comprehensive Income-34.33
Other Equity-34.33
Common Stockholder's Equity419.80
Total Stockholder's Equity419.80
Liabilities & Stockholder's Equity1,119.42
4 historic quarters locked

Sign in to unlock the full Immunocore Holdings Plc balance sheet history.

About Immunocore Holdings Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001671927-26-000022

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.